Blood Journal
Leading the way in experimental and clinical research in hematology

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

  1. Pier Mannuccio Mannucci1,
  2. Christine Kempton2,
  3. Carolyn Millar3,
  4. Edward Romond4,
  5. Amy Shapiro5,
  6. Ingvild Birschmann6,
  7. Margaret V. Ragni7,
  8. Joan Cox Gill8,
  9. Thynn Thynn Yee9,
  10. Robert Klamroth10,
  11. Wing-Yen Wong11,
  12. Miranda Chapman11,
  13. Werner Engl11,
  14. Peter L. Turecek11,
  15. Tobias M. Suiter11, and
  16. Bruce M. Ewenstein11,
  17. and members of the rVWF Ad Hoc Study Group
  1. 1Hemophilia and Thrombosis Center and Scientific Direction, IRCCS Ca’ Granda Maggiore Policlinico Hospital Foundation and University of Milan, Milan, Italy;
  2. 2Departments of Pediatrics and of Hematology and Medical Oncology, Emory University, Atlanta, GA;
  3. 3Centre for Haematology, Imperial College London, Hammersmith Hospital Campus, London, United Kingdom;
  4. 4Hemophilia Treatment Center, University of Kentucky, Lexington, KY;
  5. 5Indiana Hemophilia and Thrombosis Center, Indianapolis, IN;
  6. 6Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center, Ruhr University of Bochum, Bad Oeynhausen, Germany;
  7. 7Division Hematology/Oncology, Department of Medicine, University of Pittsburgh, and Hemophilia Center of Western Pennsylvania, Pittsburgh, PA;
  8. 8Medical College of Wisconsin and Blood Center of Wisconsin, Milwaukee, WI;
  9. 9Katharine Dormandy Haemophilia Centre, Royal Free Hospital London, London, United Kingdom;
  10. 10Vivantes Klinikum im Friedrichshain, Hemophilia Treatment Center, Berlin, Germany; and
  11. 11Baxter BioScience, Vienna, Austria and Westlake Village, CA

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview

To view this item, select one of the options below

If you already have a subscription, you may gain access using your ASH username and password.

Sign In for Institutional Administrators

If you are a Librarian or institutional account administrator you can use this link to manage your account and view usage reports.


Purchase Short-Term Access

Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00.
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

OpenAthens Users

Log in through your institution

Sign Up

Subscribe to the Journal - Subscribe to the print and/or online journal.

Access for Patients

Access for Patients - Patients desiring access should contact the journal.